Cargando…
Development and Analytical Validation of a Targeted Next-Generation Sequencing Panel to Detect Actionable Mutations for Targeted Therapy
BACKGROUND: The ability to rapidly, inexpensively, and accurately identify cancer patients based on actionable genomic mutations in tumour specimens is becoming critically important in routine clinical diagnostics. Targeted panel sequencing is becoming popular because it enables comprehensive and co...
Autores principales: | Wang, Dandan, Ma, Kai, Deng, Wei, Li, Jingyu, Xiang, Shaohua, Zhang, Yang, Fu, Ying, Dai, Heng, Huang, Bingding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039190/ https://www.ncbi.nlm.nih.gov/pubmed/33854338 http://dx.doi.org/10.2147/OTT.S299381 |
Ejemplares similares
-
Assessment of tumor mutation burden calculation from gene panel sequencing data
por: Xu, Zhenwu, et al.
Publicado: (2019) -
Development and Validation of a Targeted Next-Generation Sequencing Gene Panel for Children With Neuroinflammation
por: McCreary, Dara, et al.
Publicado: (2019) -
Validation and Clinical Application of ONCOaccuPanel for Targeted Next-Generation Sequencing of Solid Tumors
por: Kim, Moonsik, et al.
Publicado: (2023) -
Mutation Analysis of Nine Chordoma Specimens by Targeted Next-Generation Cancer Panel Sequencing
por: Fischer, Carina, et al.
Publicado: (2015) -
Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels
por: LaDuca, Holly, et al.
Publicado: (2017)